NO873495D0 - MONOCLONAL ANTIBODIES AND PEPTIDES SUITABLE FOR TREATMENT AND DIAGNOSIS OF HIV INFECTIONS. - Google Patents

MONOCLONAL ANTIBODIES AND PEPTIDES SUITABLE FOR TREATMENT AND DIAGNOSIS OF HIV INFECTIONS.

Info

Publication number
NO873495D0
NO873495D0 NO873495A NO873495A NO873495D0 NO 873495 D0 NO873495 D0 NO 873495D0 NO 873495 A NO873495 A NO 873495A NO 873495 A NO873495 A NO 873495A NO 873495 D0 NO873495 D0 NO 873495D0
Authority
NO
Norway
Prior art keywords
diagnosis
treatment
monoclonal antibodies
hiv infections
peptides suitable
Prior art date
Application number
NO873495A
Other languages
Norwegian (no)
Other versions
NO873495L (en
NO300462B1 (en
Inventor
Mary Kathleen Shriver
Elaine K Thomas
Wesley L Cosand
Larry H Gosting
Edna S Dickinson
Janela Mcclure
George J Todaro
Robert C Nowinski
Original Assignee
Genetic Systems Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genetic Systems Corp filed Critical Genetic Systems Corp
Publication of NO873495D0 publication Critical patent/NO873495D0/en
Publication of NO873495L publication Critical patent/NO873495L/en
Publication of NO300462B1 publication Critical patent/NO300462B1/en

Links

Classifications

    • FMECHANICAL ENGINEERING; LIGHTING; HEATING; WEAPONS; BLASTING
    • F04POSITIVE - DISPLACEMENT MACHINES FOR LIQUIDS; PUMPS FOR LIQUIDS OR ELASTIC FLUIDS
    • F04BPOSITIVE-DISPLACEMENT MACHINES FOR LIQUIDS; PUMPS
    • F04B25/00Multi-stage pumps
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/08Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
    • C07K16/10Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses from RNA viruses
    • C07K16/1036Retroviridae, e.g. leukemia viruses
    • C07K16/1045Lentiviridae, e.g. HIV, FIV, SIV
    • C07K16/1054Lentiviridae, e.g. HIV, FIV, SIV gag-pol, e.g. p17, p24
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/70Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage
    • C12Q1/701Specific hybridization probes
    • C12Q1/702Specific hybridization probes for retroviruses
    • C12Q1/703Viruses associated with AIDS
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00Reverse transcribing RNA viruses
    • C12N2740/00011Details
    • C12N2740/10011Retroviridae
    • C12N2740/16011Human Immunodeficiency Virus, HIV
    • C12N2740/16111Human Immunodeficiency Virus, HIV concerning HIV env
    • C12N2740/16122New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00Reverse transcribing RNA viruses
    • C12N2740/00011Details
    • C12N2740/10011Retroviridae
    • C12N2740/16011Human Immunodeficiency Virus, HIV
    • C12N2740/16211Human Immunodeficiency Virus, HIV concerning HIV gagpol
    • C12N2740/16222New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Virology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • General Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Zoology (AREA)
  • AIDS & HIV (AREA)
  • Wood Science & Technology (AREA)
  • Analytical Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Hematology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oncology (AREA)
  • Mechanical Engineering (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
NO873495A 1986-08-20 1987-08-19 Monoclonal antibodies and peptides that can be used to diagnose HIV infections NO300462B1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US89827386A 1986-08-20 1986-08-20
US4502687A 1987-05-01 1987-05-01
US6799687A 1987-06-29 1987-06-29

Publications (3)

Publication Number Publication Date
NO873495D0 true NO873495D0 (en) 1987-08-19
NO873495L NO873495L (en) 1988-02-22
NO300462B1 NO300462B1 (en) 1997-06-02

Family

ID=27366600

Family Applications (2)

Application Number Title Priority Date Filing Date
NO873495A NO300462B1 (en) 1986-08-20 1987-08-19 Monoclonal antibodies and peptides that can be used to diagnose HIV infections
NO934897A NO302176B1 (en) 1986-08-20 1993-12-29 Process for the preparation of a monoclonal antibody and an antigen

Family Applications After (1)

Application Number Title Priority Date Filing Date
NO934897A NO302176B1 (en) 1986-08-20 1993-12-29 Process for the preparation of a monoclonal antibody and an antigen

Country Status (28)

Country Link
JP (1) JPS6485928A (en)
KR (1) KR920008744B1 (en)
AT (1) AT398080B (en)
AU (1) AU616156B2 (en)
BE (1) BE1000811A4 (en)
CH (1) CH675728A5 (en)
CS (1) CS275838B6 (en)
DE (1) DE3727703A1 (en)
DK (1) DK433087A (en)
ES (1) ES2010727A6 (en)
FI (1) FI873553A (en)
FR (1) FR2603107B1 (en)
GB (1) GB2196634B (en)
GR (1) GR871298B (en)
HU (1) HU214439B (en)
IE (1) IE60671B1 (en)
IL (1) IL83580A (en)
IT (1) IT1222518B (en)
LU (1) LU86972A1 (en)
NL (1) NL8701950A (en)
NO (2) NO300462B1 (en)
NZ (1) NZ221440A (en)
OA (1) OA08652A (en)
PL (1) PL155084B1 (en)
PT (1) PT85567B (en)
SE (1) SE506025C2 (en)
YU (1) YU152587A (en)
ZW (1) ZW15487A1 (en)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AP96A (en) * 1986-06-03 1990-08-12 The Usa Dept Of Commerce Small peptides which inhibit binding to T-4 receptors and act as immunogens.
AU625720B2 (en) * 1987-05-01 1992-07-16 Genetic Systems Corporation Monoclonal antibodies to specific antigenic regions of the human immunodeficiency virus and methods for use
US6657050B1 (en) 1987-05-29 2003-12-02 Tanox, Inc. Chimeric viral-neutralizing immunoglobulins
EP0366718B1 (en) * 1987-05-29 1995-05-10 Tanox Biosystems, Inc. Monoclonal antibodies neutralizing hiv-1
US5981278A (en) * 1987-05-29 1999-11-09 Tanox, Inc. Chimeric monoclonal antibodies which neutralize HIV-1 infection and their applications in therapy and prevention for AIDS
US5834599A (en) * 1987-05-29 1998-11-10 Tanox Biosystems, Inc. Immunoconjugates which neutralize HIV-1 infection
ATE138077T1 (en) * 1988-01-26 1996-06-15 Us Health SYNTHETIC ANTIGEN FOR PRODUCING AN ANTI-HIV RESPONSE
CA1341285C (en) * 1988-02-12 2001-08-14 Chang Yi Wang Synthetic peptides for the detection of antibodies to hiv gp120 envelope protein for diagnosis of aids and pre-aids conditions and as vaccines
IL90048A0 (en) * 1988-04-25 1989-12-15 Merck & Co Inc Recombinant gag precursor of hiv,its preparation and its use as aids vaccine
US5562905A (en) * 1988-04-26 1996-10-08 E. I. Du Pont De Nemours And Company Human immunodeficiency virus (hiv) env-coded peptide capable of eliciting hiv-inhibiting antibodies in mammals
EP0339504A3 (en) * 1988-04-26 1990-09-12 The Du Pont Merck Pharmaceutical Company Human immunodeficiency virus (hiv) env-coded peptide capable of eliciting hiv-inhibiting antibodies in mammals
FR2632310B1 (en) * 1988-06-06 1992-04-10 Pasteur Institut PEPTIDES HAVING PROTECTIVE PROPERTIES OF A PATHOGENIC VIRUS OF THE HIV TYPE IN SENSITIVE CELLS
AU640619B2 (en) * 1988-10-03 1993-09-02 Repligen Corporation Hiv proteins and peptides useful in the diagnosis, prophylaxis or therapy of aids
EP0421626A1 (en) * 1989-09-19 1991-04-10 Merck & Co. Inc. Vaccine for aids and hepatitis B
SE9000333D0 (en) * 1990-01-31 1990-01-31 Britta Wahren MONOCLONAL ANTIBODY
SE468168B (en) * 1990-02-20 1992-11-16 Replico Medical Ab HIV-1, P24 PEPTIDES, DIAGNOSTIC ANTIGENS AND PROCEDURES FOR DIFFERENTIAL DIAGNOSTICS OF PRELIMINARY HIV-1 POSITIVE SERUM TESTS
JPH03271233A (en) * 1990-03-19 1991-12-03 Inst Pasteur Inducement of protective action against virus infection by synergism between peptides cor- responding to virus envelope glycoprotein and neutral epitope of its glycoprotein
CA2047042A1 (en) * 1990-07-19 1992-01-20 John Hannah Cyclic hiv principal neutralizing determinant peptides
CA2047078A1 (en) * 1990-07-19 1992-01-20 Steven S. Bondy Cyclic hiv principal neutralizing determinant peptides
JPH05310785A (en) * 1991-09-30 1993-11-22 Nitto Denko Corp Hiv-related cyclic peptide and adsorption material obtained by immobilizing the same
DK0635027T3 (en) * 1992-03-27 2000-10-02 Advanced Immunit T Inc Peptide T and related peptides for the treatment of inflammation, including disseminated sclerosis
KR20140041943A (en) 2005-12-09 2014-04-04 벡투스 바이오시스템즈 피티와이 리미티드 Vip fragments and methods of use
US8253311B2 (en) 2008-09-02 2012-08-28 Ngk Spark Plug Co., Ltd Spark plug

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9328391B1 (en) * 1984-08-22 2016-05-03 The United States Of America As Represented By The Secretary, Department Of Health And Human Services Cloning and expression of HIV-1 DNA
EP0387914B1 (en) * 1984-10-18 1993-08-04 Institut Pasteur Envelope antigens of the human immuno-deficiency virus, and their applications
GB8501473D0 (en) * 1985-01-21 1985-02-20 Pasteur Institut Cloned dna sequences
CA1341423C (en) * 1984-10-31 2003-03-04 Paul A. Luciw Recombinant proteins of viruses associated with lymphadenopathy syndrome and/or acquired immune deficiency syndrome
ES8706824A1 (en) * 1985-04-08 1987-07-01 Genetic Systems Corp EXPRESSION AND DIAGNOSTIC USE OF gag ENCODED PEPTIDES WHICH ARE IMMUNOLOGICALLY REACTIVE WITH ANTIBODIES TO LAV.
IE64785B1 (en) * 1985-04-08 1995-09-06 Genetic Systems Corp Expression of immunologically reactive viral proteins
NZ215867A (en) * 1985-04-19 1989-10-27 Hoffmann La Roche Aids envelope protein, dna vectors and method of production
WO1986006414A1 (en) * 1985-04-29 1986-11-06 Genetic Systems Corporation Synthetic antigens for the detection of aids-related disease
GB8525615D0 (en) * 1985-10-17 1985-11-20 Hoffmann La Roche Polypeptides
EP0245362B1 (en) * 1985-10-24 1994-06-29 Ronald C. Kennedy Synthetic peptides and use for diagnosis and vaccination for aids and arc
EP0245459B1 (en) * 1985-11-07 1993-09-29 The President And Fellows Of Harvard College T-cell lymphotrophic virus protein and assay
US4734362A (en) * 1986-02-03 1988-03-29 Cambridge Bioscience Corporation Process for purifying recombinant proteins, and products thereof
US4772547A (en) * 1986-02-03 1988-09-20 Hoffmann-La Roche Inc. HTLV-III envelope peptides
US4925784A (en) * 1986-04-04 1990-05-15 Hoffmann-La Roche Inc. Expression and purification of an HTLV-III gag/env gene protein
IE63109B1 (en) * 1986-06-23 1995-03-22 Genetic Systems Corp Human monoclonal antibody to lymphadenopathy-associated virus
EP0255190A3 (en) * 1986-08-01 1990-08-29 Repligen Corporation Recombinant polypeptides and their uses, inclusing assay for aids virus
JPH0762031B2 (en) * 1986-12-30 1995-07-05 アメリカ合衆国 Synthetic peptides that induce cell-mediated immunity to AIDS virus and AIDS virus proteins

Also Published As

Publication number Publication date
NO934897D0 (en) 1993-12-29
SE506025C2 (en) 1997-11-03
AU616156B2 (en) 1991-10-24
DK433087A (en) 1988-02-21
FI873553A (en) 1988-02-21
KR890002547A (en) 1989-04-10
IE60671B1 (en) 1994-08-10
FR2603107B1 (en) 1992-04-24
ZW15487A1 (en) 1988-09-14
PL267401A1 (en) 1988-07-21
NZ221440A (en) 1991-11-26
GB2196634A (en) 1988-05-05
ATA208987A (en) 1994-01-15
KR920008744B1 (en) 1992-10-09
IL83580A (en) 1992-11-15
NO873495L (en) 1988-02-22
SE8703225L (en) 1988-02-21
ES2010727A6 (en) 1989-12-01
NL8701950A (en) 1988-03-16
PT85567B (en) 1991-02-08
GB8719587D0 (en) 1987-09-23
IE872219L (en) 1988-02-20
IT8721678A0 (en) 1987-08-19
CS275838B6 (en) 1992-03-18
PL155084B1 (en) 1991-10-31
GR871298B (en) 1988-01-12
CH675728A5 (en) 1990-10-31
DE3727703A1 (en) 1988-05-05
NO300462B1 (en) 1997-06-02
JPS6485928A (en) 1989-03-30
BE1000811A4 (en) 1989-04-11
GB2196634B (en) 1991-05-15
HUT44619A (en) 1988-03-28
AT398080B (en) 1994-09-26
YU152587A (en) 1992-09-07
IT1222518B (en) 1990-09-05
FR2603107A1 (en) 1988-02-26
LU86972A1 (en) 1988-03-02
OA08652A (en) 1988-11-30
NO302176B1 (en) 1998-02-02
HU214439B (en) 1998-03-30
CS8706136A2 (en) 1990-08-14
NO934897L (en) 1993-12-29
PT85567A (en) 1987-09-01
FI873553A0 (en) 1987-08-17
AU7720187A (en) 1988-05-19
IL83580A0 (en) 1988-01-31
SE8703225D0 (en) 1987-08-19
DK433087D0 (en) 1987-08-19

Similar Documents

Publication Publication Date Title
NO873495D0 (en) MONOCLONAL ANTIBODIES AND PEPTIDES SUITABLE FOR TREATMENT AND DIAGNOSIS OF HIV INFECTIONS.
DE3586440D1 (en) FOR THE DIAGNOSIS OF HUMAN STOMACH OR BREAST CANCER MONOCLONAL ANTIBODIES TO BE USED.
DE69334246D1 (en) IMPROVED REAGENTS AND METHODS FOR THE DIAGNOSIS AND TREATMENT OF DIABETES AND STIFF MAN SYNDROME
NO870770L (en) PROCEDURE FOR THE MANUFACTURE OF MONOCLONAL ANTIBODIES.
CA2004478A1 (en) Monoclonal antibodies to feline-t-lymphotropic lentivirus
DE3872754D1 (en) DETECTION OF ANTIBODY HUMAN IMMUNDEFIZIENZ VIRUS.
NO830570L (en) ANTIBODIES AND ANTIGENS FOR CANCER DIAGNOSIS AND TREATMENT
IT1207589B (en) COMPOSITION OF CROSS-PROTECTIVE HUMAN MONOCLONAL ANTIBODIES.
DE3689948D1 (en) MONOCLONAL ANTIBODIES AND TEST PROCEDURE.
DK172686A (en) ANTIGEN DERIVED FROM HUMAN TISSUE, PROCEDURE FOR USING THE ANTIGEN TO MAKE MONOCLONAL ANTIBODIES FOR DIAGNOSIS AND TREATMENT OF CANCER, PROCEDURE FOR DETECTION OF CANCER, AND OTHER
NO885658D0 (en) RETROVIRUS EXPRESSION VECTORS AND PROCEDURES FOR MANUFACTURING HBV ANTIGEN.
DE3783401D1 (en) MEDICAL TUBE AND MANUFACTURING PROCESS.
DE3786173D1 (en) HUMAN MONOCLONAL ANTIBODY AND MEDICINES FOR PROPHYLAXIS AND TREATMENT OF INFECTIOUS DISEASES.
NO883626L (en) PROCEDURE FOR DIAGNOSIS OF PICKHOUSE AND TEST SET FOR EXECUTING THE PROCEDURE.
NO873488D0 (en) MONOCLONAL ANTIBODIES.
DK410888D0 (en) MONOCLONAL ANTIBODIES AND DIAGNOSIS PROCEDURE FOR PHYTOPHTHORA INFECTIONS
IT8241564A0 (en) MEANS FOR ITS IMPLEMENTATION. DIAGNOSTIC PROCEDURE FOR THE INDIVIDUALIZATION OF CARRIERS OF THE BETA-THALASSEMIC CHARACTER AND
DE3872790D1 (en) DEVICE FOR THE EXAMINATION OF ZIPPER ELEMENTS.
NO871484D0 (en) PROCEDURE FOR THE PREPARATION OF N- (SULPHONYLMETHYL) FORMAMIDS.
NO872633L (en) MONOCLONAL ANTIBODY AGAINST HUMAN PLASMINOGEN, AND PREPARATION OF THEREOF.
DE3788424D1 (en) TEST PROCEDURE OF THE HUMAN B-LYMPHOTROPIC VIRUS (HBLV).
NO914755L (en) PEPTIDES AND THEREFORE DERIVATIVE ANTIBODIES FOR DIAGNOSIS OF, THERAPY AND VACCINATION FOR HTLV-1 INFECTION
ZM6687A1 (en) Monoclonal antibodies and peptides useful in treating and diagnosing hiv infections